Rugby legend Jonathan Thurston becomes Gameday’s newest ambassador


Published 26-MAY-2017 12:57 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

In a major coup for Impression Healthcare (ASX: IHL), the company has appointed National Rugby League (NRL) legend Johnathan Thurston as its latest Gameday Ambassador.

This development resulted in IHL’s shares surging nearly 10% on Friday morning.

It should be noted that share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.

Over a long career as a high profile rugby league player from international to club level, Johnathan Thurston has been the face of Australian rugby league, demonstrating exceptional talents and sportsmanship, as well as having a likeable demeanour off the field.

He already has a well renowned habit in terms of protective equipment, always giving a child in the grandstands his protective headgear, both at half-time and full-time.

During his career Thurston has won the Dally M Player of the Year Award four times and the Golden Boot Award for the world’s best player on three occasions.

His position as a legend of the game is supported by an astounding performance, having notched up the most career points and career goals for the Australian Test team and also the most career points and goals in State of Origin football, widely viewed as the pinnacle of rugby league representation, even at an international level.

Thurston is particularly popular in Queensland, a state where rugby league has a strong foothold, and is played extensively in schools, a mass-market in its own right and one where affordability often stands in the way of children being able to wear properly fitted mouthguards.

Consequently, this is an important market for IHL’s affordable high-quality mouthguards, as they provide parents with an option compared with the substantially more expensive mouthguards that are fitted by a dentist.

IHL has negotiated a 12 month contract which includes the option to extend for an additional 12 months. During this time Thurston will use his professional profile to promote Gameday mouthguards.

In this capacity he will be featured in company marketing materials including digital advertising, electronic direct mailings, and also in a Gamedy Mouthguard’s television commercial.

Marketing activity will coincide with major events such as State of Origin and other significant NRL events. Thurston will also launch his own limited edition range of mouthguards under the agreement.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free